title: The use of serologic tests for Lyme disease in a prepaid health plan in California.
abstract: OBJECTIVE
  To determine the reason(s) why serologic tests for Lyme disease are performed, who initiates the test requests, and how the test results are used in a clinical setting.
  
  
  METHODS
  Retrospective cohort.
  
  
  METHODS
  Prepaid health plan in northern California.
  
  
  METHODS
  Consecutive sample of 117 patients for whom at least one serologic test for Lyme disease was performed during a 3-month period.
  
  
  METHODS
  Reason for ordering and result of the serologic test, differential diagnoses, and treatment.
  
  
  RESULTS
  One of 117 patients had antibodies to Borrelia burgdorferi. Fifty-six percent of test requests were initiated by the physician and 35% by the patient. Of 66 tests ordered by the physician, 20% were performed because of suspected early Lyme disease, 6% as follow-up of a tick bite, 2% to confirm a prior history of Lyme disease, 14% as a workup for arthritis, and 60% as one of a battery of laboratory tests for vague symptoms. Of 41 tests initiated by the patient, 51% were performed because of a history of a tick bite. The reasons for ordering 10 tests were undetermined.
  
  
  CONCLUSIONS
  Only 19% of all serologic tests for Lyme disease were performed because the physician suspected Lyme disease in the patient. Particularly in light of the low probability of contracting Lyme disease in California, it appears that this serologic test is being overused. Indiscriminate testing increases health care costs and does not appear to affect treatment decisions. Education is needed regarding the limitations of this serologic test.
authors.affiliation: Epidemiology Program, School of Public Health, University of California, Berkeley 94720.
authors.forename: C
authors.initials: C
authors.lastname: Ley
authors.forename: C
authors.initials: C
authors.lastname: Le
authors.forename: E M
authors.initials: EM
authors.lastname: Olshen
authors.forename: A L
authors.initials: AL
authors.lastname: Reingold
mesh_terms: D002140:California; D015331:Cohort Studies; D006403:Hematologic Tests / Q000706:statistics & numerical data*; D006801:Humans; D008193:Lyme Disease / Q000097:blood / Q000175:diagnosis*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D017061:Prepaid Health Plans / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D012698:Serologic Tests / Q000706:statistics & numerical data